Back to search

Article

Risk of Appropriate Implantable Cardioverter-Defibrillator Therapies and Sudden Cardiac Death in Patients With Heart Failure With Improved Left Ventricular Ejection Fraction

2023-03-07

Abstract excerpt

<h4>Background: </h4> The benefit of implantable cardioverter defibrillator (ICD) therapy in patients who have heart failure with improved left ventricular ejection fraction (LVEF) to >35% after implantation (HFimpEF) is controversial. <h4>Methods: </h4> Databases (Ovid MEDLINE, EMBASE, Web of Science, and Google Scholar) were queried for studies of ICD patients that reported the association between HFimpEF and a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9a0e806b-74e8-5189-9e74-5fc351270d6d
DOI
10.22541/au.167821396.66197879/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Risk of Appropriate Implantable Cardioverter-Defibrillator Therapies and Sudden Cardiac Death in Patients With Heart Failure With Improved Left Ventricular Ejection FractionDOI 10.22541/au.167821396.66197879/v1
Select a neighboring publication to make it the new centre.